Endowed through a generous gift from Mary Ann and Charles LaBahn, the Pancreatic Cancer Program is comprised of a multidisciplinary team of physicians, scientists, and dedicated staff who share the LaBahns' passion and urgency for making significant progress in the battle against pancreatic cancer.

The Mary Ann and Charles LaBahn Pancreatic Cancer Program serves as a hub for innovation where physicians and scientists are focused on providing hope for a cure to patients and families with pancreatic cancer. The LaBahns’ generosity allows for high-risk, high-reward research leading toward more effective therapies and treatment options for patients with this devastating disease. This philanthropic investment will hasten the pace at which our team can translate laboratory discoveries into treatments for patients.